About Zeiss

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 6.4 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2019).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world’s leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company’s significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS’ technology and market leadership.

With over 31,000 employees, ZEISS is active globally in almost 50 countries with around 60 sales and service companies, 30 production sites and 25 development sites. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Contact

Carl-Zeiss-Straße 22
73447 Oberkochen
Germany

info.de@zeiss.com
+49 7364 20-0

https://www.zeiss.com/

Toepassingen

Aanvullen

Technologieën

Aanvullen

Thema’s

Aanvullen

Gepubliceerde artikelen

RAAK MKB Indieningsronde maart 2021

Op deze pagina vind je in het kort de belangrijkste informatie…
14 januari 2021/door Aurélie Veltema

DSM en TU Delft realiseren laboratorium voor kunstmatige intelligentie als stimulans voor biowetenschappelijke innovatie

Koninklijke DSM, een wereldwijd bedrijf dat vanuit wetenschappelijke…
14 januari 2021/door Aurélie Veltema

MinacNed pre-events in 2021: We hebben uw input nodig

In 2021 gaat het MinacNed team door met organiseren van de iMNC-pre-events,…
13 januari 2021/door Aurélie Veltema

QuTech, KPN, SURF en OPNT bouwen samen aan quantumnetwerk

QuTech (een samenwerking tussen TU Delft en TNO), KPN, SURF en…
11 januari 2021/door Aurélie Veltema

MinacNed members showcase their company in promotional video

To showcase the partners in the nanotechnology ecosytem, MinacNed…
6 januari 2021/door Aurélie Veltema

Key Technologies pre-registration call

Consortia including research institutes and public and private…
9 december 2020/door Aurélie Veltema

Venture Challenge: Registration open for new edition

From this week onwards, starting entrepreneurs in the…
8 december 2020/door Aurélie Veltema

Open platform technologies can give medical start-ups a boost

The medical market can learn a thing from the consumer electronics…
1 december 2020/door Aurélie Veltema

13 New SME-deals for regional support of SME’s

With 13 new SME deals, the Ministry of Economic Affairs and Climate…
26 november 2020/door Aurélie Veltema

Highlights in the iMNC2020-program according to Maarten Honing

By Dimitri Reijerman, FHI

Because of the corona pandemic,…
25 november 2020/door Aurélie Veltema

16th edition of the International MicroNanoConference 2020 fully digital

On 3 and 4 December 2020, MinacNed, in collaboration with its…
20 november 2020/door Aurélie Veltema

Doe een voorstel voor een innovatieve oplossing voor de vaccinatielogistiek!

Er wordt hard gewerkt aan vaccins die we begin volgend jaar verwachten.…
19 november 2020/door Aurélie Veltema